BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17122157)

  • 1. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease.
    Verstappen J; Von den Hoff JW
    J Dent Res; 2006 Dec; 85(12):1074-84. PubMed ID: 17122157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMPs and TIMPs expression in facial tissue of children with cleft lip and palate.
    Smane-Filipova L; Pilmane M; Akota I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):538-542. PubMed ID: 27876897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases: their biological functions and clinical implications.
    Hijova E
    Bratisl Lek Listy; 2005; 106(3):127-32. PubMed ID: 16026148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternate perspective on the roles of TIMPs and MMPs in pathology.
    Moore CS; Crocker SJ
    Am J Pathol; 2012 Jan; 180(1):12-6. PubMed ID: 22033229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?
    Séguier S; Gogly B; Bodineau A; Godeau G; Brousse N
    J Periodontol; 2001 Oct; 72(10):1398-406. PubMed ID: 11699482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel functions of TIMPs in cell signaling.
    Chirco R; Liu XW; Jung KK; Kim HR
    Cancer Metastasis Rev; 2006 Mar; 25(1):99-113. PubMed ID: 16680576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
    Karthikeyan VJ; Lane DA; Beevers DG; Lip GY; Blann AD
    J Hum Hypertens; 2013 Feb; 27(2):72-8. PubMed ID: 22418748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
    De S; Fenton JE; Jones AS
    J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.
    Bourboulia D; Stetler-Stevenson WG
    Semin Cancer Biol; 2010 Jun; 20(3):161-8. PubMed ID: 20470890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases involvement in pathologic conditions.
    Amălinei C; Căruntu ID; Giuşcă SE; Bălan RA
    Rom J Morphol Embryol; 2010; 51(2):215-28. PubMed ID: 20495735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
    Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
    Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
    Guenzinger R; Lahm H; Wottke M; Lange R
    ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
    Varghese S
    Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.